Form 8-K - Current report:
SEC Accession No. 0001213900-21-054869
Filing Date
2021-10-27
Accepted
2021-10-27 16:30:33
Documents
14
Period of Report
2021-10-01
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea149452-8k_silopharma.htm   iXBRL 8-K 21626
2 FORM OF SPONSORED RESEARCH AGREEMENT ea149452ex10-1_silopharma.htm EX-10.1 122878
3 PRESS RELEASE DATED OCTOBER 27, 2021 ea149452ex99-1_silopharma.htm EX-99.1 6756
  Complete submission text file 0001213900-21-054869.txt   344611

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE silo-20211001.xsd EX-101.SCH 3031
5 XBRL LABEL FILE silo-20211001_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE silo-20211001_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea149452-8k_silopharma_htm.xml XML 3282
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54872 | Film No.: 211353378
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl